Indian Journal of Private Psychiatry

Register      Login

VOLUME 14 , ISSUE 2 ( July-December, 2020 ) > List of Articles

REVIEW ARTICLE

Psychodermatology: An Overview of History, Concept, Classification, and Current Status

Ravindra Neelakanthappa Munoli

Keywords : Classification in psychodermatology, Definition of psychodermatology, History of psychodermatology, Psychodermatology, Psychodermatology clinic, Psychodermatology in India, Stress and psychodermatology

Citation Information : Munoli RN. Psychodermatology: An Overview of History, Concept, Classification, and Current Status. Ind J Priv Psychiatry 2020; 14 (2):85-91.

DOI: 10.5005/jp-journals-10067-0067

License: CC BY-NC 4.0

Published Online: 31-07-2021

Copyright Statement:  Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Psychodermatology is an evolving discipline of medicine with an interface of dermatology and psychiatry. Current psychodermatology relies on understanding that biological, psychological, and social factors play roles in the disease etiopathogenesis. These interactions can be seen over the entire disease course. Recent research addressed the embryological and physiological connections between skin and nervous system, which get reflected in many dermatoses. Various classifications have evolved to understand psychodermatological disorders but there is lack of consensus on definition and classification. Though various models of clinics have shaped up, a holistic approach by liaison between psychiatrist, dermatologist, and psychologist will be ideal to address these. Current review addresses history and evolution of psychodermatology, defines psychodermatology, discusses classification, and explores pathophysiological aspects.


PDF Share
  1. Schaller C. Die Haut alsGrenzorgan und Beziehungsfeld. In: Tress W (Hrsg) Psychosomatische Grundversorgung, 2. Aufl. Stuttgart: Schattauer; 1997. p. S94–S96.
  2. Sack T, 1928. In: Whitlock FA. Psychophysiological aspects of skin disease. London: WB Saunders Limited; 1976.
  3. Anzieu D, Das Haut-IchAufl, Frankfurt AM: Suhrkamp Verlag; 1992.
  4. Van Moffaert M. Psychodermatology: an overview. Psychother Psychosom 1992;58:125–136. DOI: 10.1159/000288621.
  5. Gupta MA, Gupta AK, Ellis CN, et al. Psychiatric evaluation of the dermatology patient. Dermatol Clin 2005;23:591–599. DOI: 10.1016/j.det.2005.05.005.
  6. Gupta MA, Gupta AK. Psychodermatology: an update. J Am Acad Dermatol 1996;34:1030–1046. DOI: 10.1016/s0190-9622(96)90284-4.
  7. Wessely SC, Lewis GH. The classification of psychiatric morbidity in attenders at a dermatology clinic. Br J Psychiatry 1989;155:686–691. DOI: 10.1192/s0007125000018201.
  8. Koo J. Psychodermatology: a practical manual for clinicians. Curr Probl Dermatol 1995;7:203–225.DOI: 10.1016/S1040-0486(09)80012-4.
  9. Jafferany M, Ferreira BR, Patel A. The essentials of psychodermatology. Cham, Switzerland: Springer International Publishing; 2020. p. 29–34.
  10. Linthorst Homan MW, Spuls PI, de Korte J, et al. The burden of vitiligo: patient characteristics associated with quality of life. J Am Acad Dermato 2009;61:411–420. DOI: 10.1016/j.jaad.2009.03.022.
  11. Linthorst Homan MW, de Korte J, Grootenhuis MA, et al. Impact of childhood vitiligo on adult life. Br J Dermatol 2008;159:915–920. DOI: 10.1111/j.1365-2133.2008.08788.x.
  12. Cossidente A, Sarti MG. History and fundamentals of psychosomatic dermatology. Clin Dermatol 1984;2:1–16.DOI: 10.1016/0738-081x(84)90042-7.
  13. Poot F, Sampogna F, Onnis L. Basic knowledge in psychodermatology. J Eur Acad Dermatol Venereol 2007:21:227–234. DOI: 10.1111/j.1468-3083.2006.01910.x.
  14. Shafii M, Shafii S. Exploratory psychotherapy in the treatment of psoriasis. Twelve hundred years ago. Arch Gen Psychiatry 1979;36:1242–1245. DOI: 10.1001/archpsyc.1979.01780110096012.
  15. França K, Castillo DE, Roccia MG, et al. Psychoneurocutaneous medicine: past, present and future. Wien Med Wochenschr2017;167:31–36. DOI: 10.1007/s10354-017-0573-3.
  16. França K, Chacon A, Ledon J, et al. Psychodermatology: a trip through history. An Bras Dermatol2013;88:842–843. DOI: 10.1590/abd1806-4841.20132059.
  17. Elangasinghe V, Lee KYC, Levell NJ. An historical account of dermato-logy in Buddhist Sri Lankan literature. Int J Dermatol2014;53:390–392. DOI: 10.1111/ijd.12422.
  18. Singh S, Tripathi JS, Rai NP. An overview of Ayurvedic & contemporary approaches to psychodermatology. J Phytopharmacol2014; 3:286–299. http://www.phytopharmajournal.com/Vol3_Issue4_10.pdf
  19. Rodríguez-Cerdeira C, Pera-Grasa J, Molares A, et al. Psychoder-matology: past, present and future. Open Dermatol J2015;5:21–27. DOI: 10.1007/s10354-017-0573-3.
  20. Koo JY, Pham CT. Psychodermatology. Practical guidelines on pharmacotherapy. Arch Dermatol 1992;128:381–388. DOI: 10.1001/archderm.128.3.381.
  21. Bjornsson AS, Didie ER, Phillips KA. Body dysmorphic disorder. Dialogues Clin Neurosci 2010;12(2):221–232.DOI: 10.31887/DCNS.2010.12.2/abjornsson.
  22. Freud S. The wolfman and other cases. London: Penguin Books; 2002.
  23. Klauder JV. Syphilis and the characters in Ibsen's Dramas. Ann Med Hist 1936;8(3):236–241.
  24. https://pdai.in/about.php[Last Accessed on 15 April 2021].
  25. Shenoi SD, Prabhu S, Nirmal B, et al. Our experience in a psychodermatology liaison clinic at Manipal, India. Indian J Dermatol 2013;58:53–55. DOI: 10.4103/0019-5154.105310.
  26. Brar BK, Brar SK, Puri N, et al. Psychodermatology liaison clinic at a tertiary care centre in North India. Sch J App Med Sci 2016;4:2795–2798.DOI:10.21276/sjams.2016.4.8.14.
  27. Bewley A, Magid M, Reichenberg JS, et al. Introduction. In: Bewley A, Taylor RE, Reichenberg JS, et al., editors. Practical psychodermatology. Chichester, UK: Wiley Blackwell; 2014. p. 3–10.
  28. Reichenberg JS, Kroumpouzos G, Magid M. Approach to a psychodermatology patient. G Ital Dermatol Venereol2018;153:494–496. DOI: 10.23736/S0392-0488.18.05965-5.
  29. Koo JYM, Lee CS. General approach to evaluating psychoder-matological disorders. In: Koo JYM, Lee CS, editors. Psychocutaneous medicine. Basic and clinical dermatology. New York, NY: Marcel Dekker; 2003. p.1–12.
  30. Ferreira BR, Jafferany M, Patel A. Classification and terminology of psychodermatologic disorders. In: Jafferany M, Ferreira BR, Patel A, authors. The essentials of psychodermatology. Cham, Switzerland AG: Springer International Publishing; 2020. p. 37–46.
  31. Ferreira BR, Jafferany M. Classification of psychodermatological disorders. J Cosmet Dermatol2021:1–3. DOI: 10.1111/jocd.14112
  32. Tareen RS. Pediatric psychodermatology: a clinical manual of child and adolescent psychocutaneous disorders. Berlin: De Gruyter; 2013.
  33. Jafferany M, França K. Geriatric psychodermatology: psychocutaneous disorders in the elderly. New York: Nova Science; 2015.
  34. França K, Panchaprateep R, Tosti A. Optimal patient management of alopecia. Oxford: Gardner Healthcare Communications; 2015.
  35. França K, Nouri K. Psycodermato-oncology: skin cancers in the elderly. In: Jafferany M, França K, editors. Geriatric psychodermatology: psychocutaneous disorders in the elderly. New York: Nova Science; 2015. p. 187–193.
  36. Castillo D.E., França K., Lotti T. Psychological approach in cosmetic dermatology. In: Issa M, Tamura B, editors. Daily routine in cosmetic dermatology. Clinical approaches and procedures in cosmetic dermatology. Cham: Springer; 2016. DOI: 10.1007/978-3-319-20250-1_3-1 (Last accessed on 15 April 2021).
  37. Tyring S, Lupi O, Hengge U. Tropical dermatology. Edinburgh: Churchill Livingstone; 2006.
  38. Freiman A, Barankin B, Elpern D. Sports dermatology part 1: common dermatoses. Can Med Assoc J2004;171:851–853. DOI: 10.1503/cmaj.1041143.
  39. França K, França A, França R. Environmental psychodermatology: stress, environment and skin. In: França K, Jafferany M, editors. Stress and skin disorders. Heidelberg: Springer; 2017. p. 47–53.
  40. Bolognia JL, Schaffer JV, Duncan KO, KoCJ. Dermatology essentials e-book. United States: Elsevier Health Sciences; 2014.
  41. Gupta MA, Voorhees JJ. Psychosomatic dermatology: is it relevant? Arch Dermatol 1990;126:90–93. DOI: 10.1001/archderm.1990.01670250096016.
  42. Korabel H, Dudek D, Jaworek A, et al. Psychodermatology: psychological and psychiatrical aspects of dermatology. Przegl Lek2008;65:244–248. PMID: 18853651.
  43. Turk T, Dytoc M, Youngson E, et al. Estimated frequency of psychodermatologic conditions in Alberta, Canada. J Cutan Med Surg 2021;25:30–37. DOI: 10.1177/1203475420952424.
  44. Hu SCS, Chen GS, Tu HP. Epidemiology of depression in patients with psoriasis: a nationwide population-based cross-sectional study. Acta Derm Venereol 2019;99:530–538. DOI:10.2340/00015555-3145.
  45. Picardi A, Abeni D. Stressful life events and skin diseases: disentangling evidence from myth. Psychother Psychosom 2001;70:118–136. DOI: 10.1159/000056237.
  46. Colón EA, Popkin MK, Callies AL, et al. Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Compr Psychiatry 1991;32:245–251. DOI: 10.1016/0010-440X(91)90045-E.
  47. Yaghmaie P, Koudelka CW, Simpson EL. Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol 2013;13: 428–433. DOI: 10.1016/j.jaci.2012.10.041.
  48. Miniksar DY, Özcan ÖÖ, Cenk H, et al. Psychiatric morbidity in children and adolescents with dermatological disorders. Scand J Child Adolesc Psychiatr Psychol 2021;9:1–8. DOI: 10.21307/sjcapp-2021-001.
  49. Goyal N, Shenoi S, Prabhu SS, et al. Psychodermatology liaison clinic in India: a working model. Trop Doct2018;48:7–11. DOI: 10.1177/0049475517736708.
  50. Raikhy S, Gautam S, Kanodia S. Pattern and prevalence of psychiatric disorders among patients attending dermatology OPD. Asian J Psychiatr 2017;29:85–88. DOI: 10.1016/j.ajp.2017.04.018.
  51. Pulimood S, Rajagopalan B, Rajagopalan M, et al. Psychiatric morbidity among dermatology inpatients. Natl Med J India 1996;9:208–210.
  52. Shenoi SD, Prabhu SS. Psychodermatology: an Indian perspective. Clin Dermatol 2018;36:737–742. DOI: 10.1016/j.clindermatol.2018.08.013.
  53. Gaikwad R, Deshpande S, Raje S, et al. Evaluation of functional impairment in psoriasis. Indian J Dermatol VenereolLeprol2006;72:37–40. DOI: 10.4103/0378-6323.19716.
  54. Rakesh SV, D'Souza M, Sahai A. Quality of life in psoriasis: a study from south India. Indian J Dermatol VenereolLeprol 2008;74:600–606. DOI: 10.4103/0378-6323.45101.
  55. Chaudhury S, Das AL, John RT, et al. Psychological factors in psoriasis. Indian J Psychiatry 1998;40:295–299. PMID: 21494487; PMCID: PMC2966606.
  56. Malhotra SK, Mehta V. Role of stressful life events in induction or exacerbation of psoriasis and chronic urticaria. Indian J Dermatol Venereol Leprol 2008;74:594–599. DOI: 10.4103/0378-6323.45100.
  57. Mattoo SK, Handa S, Kaur I, et al. Psychiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol2002;16:573–578. DOI: 10.1046/j.1468-3083.2002.00590.x.
  58. Karia SB, De Sousa A, Shah N, et al. Psychiatric morbidity and quality of life in skin diseases: a comparison of alopecia areata and psoriasis. Ind Psychiatry J2015;24:125–128. DOI: 10.4103/0972-6748.181724.
  59. Vallerand IA, Lewinson RT, Parsons LM, et al. Assessment of a bidirectional association between major depressive disorder and alopecia areata. JAMA Dermatol 2019;155:475–479. DOI: 10.1001/jamadermatol.2018.4398.
  60. Vallerand IA, Lewinson RT, Parsons LM, et al. Vitiligo and major depressive disorder: a bidirectional population-based cohort study. J Am Acad Dermatol 2019;80:1371–1379. DOI: 10.1016/j.jaad.2018.11.047.
  61. Bharath S, Shamasundar C, Raghuram R, et al. Psychiatric morbidity in leprosy and psoriasis--a comparative study. Indian J Lepr1997;69: 341–346. PMID: 9474509.
  62. Neerackal RJ, Abdul Latheef EN, Sukumarakurup S, et al. Relaxation therapy in the management of psoriasis. Dermatol Ther 2020;33:e14030. DOI: 10.1111/dth.14030.
  63. Kumar V, Mattoo SK, Handa S. Psychiatric morbidity in pemphigus and psoriasis: A comparative study from India. Asian J Psychiatr 2013;6:151–156. DOI: 10.1016/j.ajp.2012.10.005.
  64. Sarkar R, Raj L, Kaur H, et al. Psychological disturbances in Indian children with atopic eczema. J Dermatol2004;31:448–454. DOI: 10.1111/j.1346-8138.2004.tb00530.x.
  65. Malhotra S, Grover S, Baweja R, et al. Trichotillomania in children. Indian Pediatr 2008;45:403–405.
  66. Detig-Kohler C. Hautnah: Impsychoanalytischen Dialog mitHautkranken. Giessen: Psychosozial Verlag; 2002.
  67. Bick E. Hauterfahrung in frühen Objektbezieheung. Int J Psycho Anal 1968;49:484. PMID: 5698219.
  68. Koblenzer C, Koblenzer P. Chronic intractable atopic eczema. Its occurrence as a physical sign of impaired parent-child relationships and psychologic development arrest: improvement through parent insight and education. Arch Dermatol 1988;124:1673–1677. DOI: 10.1001/archderm.124.11.1673.
  69. Dhabhar FS. Psychological stress and immunoprotection vs. immunopathology in the skin. Clin Dermatol2013;31:18–30. DOI: 10.1016/j.clindermatol.2011.11.003.
  70. Jafferany M, Patel A. Understanding psychocutaneous disease: psychosocial &psychoneuroimmunologic perspectives. Int J Dermatol 2019;59:8–15. DOI: 10.1111/ijd.14629.
  71. Jafferany M, Salimi S, Mkhoyan R, et al. Psychological aspects of aesthetic and cosmetic surgery: clinical and therapeutic implications. Dermatol Ther 2020;33:e13727.DOI: 10.1111/dth.13727.
  72. Hafi B, Uvais NA, Jafferany M, et al. Palliative psychodermatology care during COVID-19 pandemic. Dermatol Ther 2020;33:e13732. DOI: 10.1111/dth.13732.
  73. O'Neill CA, Monteleone G, McLaughlin JT, et al. The gut-skin axis in health and disease: a paradigm with therapeutic implications. Bio Essays 2016;38:1167–1176. DOI: 10.1002/bies.201600008.
  74. França K, Lotti TM. Psycho-neuro-endocrine-immunology: apsychobiological concept. Adv Exp Med Biol 2017;996:123–134. DOI: 10.1007/978-3-319-56017-5_11.
  75. Arck P, Handjiski B, Hagen E, et al. Is there a ‘gut-brain-skin axis’? Exp Dermatol 2010;19:401–405.DOI: 10.1111/j.1600-0625.2009.01060.x.
  76. Bowe WP, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis—back to the future? Gut Pathog 2011;3:1. DOI: 10.1186/1757-4749-3-1
  77. Soderholm JD, Perdue MH. Stress and gastrointestinal tract. II. Stress and intestinal barrier function. Am J Physiol Gastrointest Liver Physiol 2001;280:G7–G13.DOI: 10.1152/ajpgi.2001.280.1.G7.
  78. Myles IA, Williams KW, Reckhow JD, et al. Transplantation of human skin microbiota in models of atopic dermatitis. JCI Insight 2016;7;1:e86955. DOI: 10.1172/jci.insight.86955.
  79. Ganju P, Nagpal S, Mohammed MH, et al. Microbial community profiling shows dysbiosis in the lesional skin of Vitiligo subjects. Sci Rep 2016;13;6:18761. DOI: 10.1038/srep18761.
  80. Lotti T, Hercogova J, Wollina U, et al. Psycho-neuro-endocrine-immunology and low dose cytokines therapy: principles and evidences for an innovative medical approach in acute and chronic inflammatory diseases. J Biol RegulHomeost Agents 2015;29 (1 Suppl):37–45. PMID: 26016967.
  81. Toups M. Inflammation and depression: the neuroimmune connection. Curr Treat Options Psychiatry 2018;5:452–458. DOI: 10.1007/s40501-018-0157-x.
  82. Finlay AY, Khan GK. Dermatology life quality index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol1994;19:210–216. DOI: 10.1111/j.1365-2230.1994.tb01167.x.
  83. Patel A, Jafferany M. Multidisciplinary and holistic models of care for patients with dermatologic disease and psychosocial comorbidity: a systematic review. JAMA Dermatol 2020;156:686–694. DOI: 10.1001/jamadermatol.2020.0394.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.